Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
about
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in womenTreatment of acute pelvic inflammatory diseaseAntibiotic therapy for pelvic inflammatory disease (PID)Unexpected gynecologic findings during abdominal surgeryPelvic inflammatory disease: improving awareness, prevention, and treatmentPelvic inflammatory disease.The clinical diagnosis of pelvic inflammatory disease--reuse of electronic medical record data from 189 patients visiting a Swedish university hospital emergency department.Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approachRandomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trialCurrent perspectives in the USA on the diagnosis and treatment of pelvic inflammatory disease in adolescents.Status of adolescent pelvic inflammatory disease management in the United States.The effectiveness of nonsteroidal anti-inflammatory agents in the treatment of pelvic inflammatory disease: a systematic reviewComparison of Genital Chlamydia trachomatis Infection Incidence Between Women With Infertility and Healthy Women in Iran Using PCR and Immunofluorescence Methods.Recommendations and rationale for the treatment of pelvic inflammatory disease.Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatmentPelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatmentSexually transmitted diseases treatment guidelines, 2015.Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate modelManagement of Chlamydia trachomatis genital tract infection: screening and treatment challenges.Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort studyCost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.Azithromycin for PID beats doxycycline on all counts.The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory diseaseEndometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection.Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease researchAdverse adolescent reproductive health outcomes after pelvic inflammatory disease.Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease.Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory diseaseProtecting adolescents' right to seek treatment for sexually transmitted diseases without parental consent: the Arizona experience with Senate Bill 1309.Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?Racial variation in toll-like receptor variants among women with pelvic inflammatory diseaseEvaluation of endometrium for chronic endometritis by using syndecan-1 in abnormal uterine bleeding.Proteomic identification of immunodominant chlamydial antigens in a mouse modelNewest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
P2860
Q21131426-7DE6B293-C1AD-4BFC-AB85-13F7A19E561DQ21296776-ED8C362A-1E6F-4833-BAD8-368E60C2455BQ24201906-2826B2D7-1647-4259-B675-C9C3DD62CCA3Q26828571-47E6BA6B-EB90-449F-9535-888CFCB030CDQ26992247-B481A83A-0FBA-448E-8D7B-4DFC7BA4B32FQ27345155-B0EAB612-BC38-459E-A671-B6053DC62D0FQ31068513-7FD16075-B742-4BC1-B090-5102E2D8E16EQ33769215-4CCB8AAA-CDD4-42A8-B218-FADB21CFDC2FQ33778605-C3B28101-D1CA-4D21-83D1-094F50564C55Q33876046-6025000A-6F48-48A0-9F33-3EDA591E8BC3Q33886634-C21526E8-64B2-472B-B325-2E5CA74F2919Q34017449-7B8D9E7D-CCAE-40AE-B29B-ED2C817EFA1EQ34068570-C3B620BE-4E61-40AA-9EA0-D3BDBDB5C88EQ34155769-91B73A5C-71BD-4C2E-99E1-205923AAB3C6Q34311438-BB235E0C-2E95-4935-AA5C-88D20B0C9766Q34381731-6A3DED5A-9393-4D4C-BC78-13AA6992CFCEQ34387781-1C6DD533-537B-433F-9735-86F56F4A5316Q34479272-14286B53-657F-46C3-B090-D72575D85713Q34558039-D01947CB-DE66-4115-8C75-BE61DBBDC300Q34591252-4992B99D-480B-4250-A199-BD75307B5234Q34886221-FF698FF9-0096-42BC-B333-08C0CD7D9627Q35026625-40626380-C257-45CE-9B17-36D006FB233EQ35056772-C6D4582F-ED28-46A4-AB39-0CC88CC5F9A9Q35151821-41D450CC-201E-4012-B6D9-9B330A7BDE6DQ35167336-8DECF82A-5C51-4C83-8D95-683F792B5D8AQ35246485-055980B6-47F1-461D-BAB7-6B78262798B5Q35417872-B607DF3C-86EF-48A2-9BE9-564EE644B9E3Q35478440-7C77351C-7E38-4D76-8F75-D77AB5177963Q35549536-4F482572-9F45-4879-8940-A3038F60E845Q35557924-5014C846-67E7-43FD-A609-1DB69E1129C4Q35586138-017A5D14-7E66-4953-BDDF-429C89FA9947Q35659940-4E5F8A53-DAEE-4301-B3D8-888A44334A09Q35694671-930CA038-29A1-47ED-8ADB-B48CE95575E1Q35856824-64F11554-9703-494F-9490-F988B36017A6Q36441494-0BC2B8CE-6190-41AA-826A-564DFC8820C4Q36580740-36CA50DD-6467-4BC0-9B34-D10AC8D29B5EQ36607271-39979FE5-146A-4357-AFF7-A012117F7164Q36615648-D619B7DD-C59F-4098-841C-84D37281B524Q36619644-D5BCA220-7707-4ADE-AC5E-9367228751BAQ36753460-2A2B39FD-DBE8-422C-99E3-C4A4DECDD1E9
P2860
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Effectiveness of inpatient and ...... alth (PEACH) Randomized Trial.
@en
Effectiveness of inpatient and ...... Evaluation and Clinical Health
@nl
type
label
Effectiveness of inpatient and ...... alth (PEACH) Randomized Trial.
@en
Effectiveness of inpatient and ...... Evaluation and Clinical Health
@nl
prefLabel
Effectiveness of inpatient and ...... alth (PEACH) Randomized Trial.
@en
Effectiveness of inpatient and ...... Evaluation and Clinical Health
@nl
P2093
P356
P1476
Effectiveness of inpatient and ...... alth (PEACH) Randomized Trial.
@en
P2093
Antonio Amortegui
David E Soper
Debra C Bass
Giuliana Trucco
Hugh Randall
Jeffrey Peipert
Judith R Lave
Richard L Sweet
Robert L Holley
Roberta B Ness
P304
P356
10.1067/MOB.2002.121625
P407
P577
2002-05-01T00:00:00Z